ALSUntangled #75: Portable neuromodulation stimulator therapy.

Area of Science:

• Neurology
• Biomedical Engineering

Background:

• Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease.
• Patient interest has prompted an examination of the Portable Neuromodulation Stimulator (PoNS™) for ALS treatment.
• The PoNS™ device is FDA-approved for multiple sclerosis gait deficits.

Purpose of the Study:

• To evaluate the potential of the PoNS™ device for treating amyotrophic lateral sclerosis (ALS).
• To review existing data on PoNS™ efficacy in other neurological conditions.

Main Methods:

• Literature review of PoNS™ technology and its application in neurological disorders.
• Analysis of the PoNS™ mechanism involving translingual neurostimulation.
• Assessment of safety, cost, and accessibility factors.

Main Results:

• PoNS™ utilizes translingual neurostimulation to induce neuroplastic changes.
• Promising data exists for PoNS™ in multiple sclerosis, stroke, and traumatic brain injury.
• No pre-clinical or clinical studies specific to ALS have been conducted.

Conclusions:

• The PoNS™ device has demonstrated efficacy in improving gait and balance in other neurological conditions.
• Lack of ALS-specific data prevents endorsement of PoNS™ for ALS treatment.
• High costs and prescription requirements may limit PoNS™ accessibility.